Literature DB >> 25122798

Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.

Justin H Hwang1, Arun T Pores Fernando2, Nathalie Faure3, Shaida Andrabi4, Guillaume Adelmant, William C Hahn5, Jarrod A Marto, Brian S Schaffhausen6, Thomas M Roberts7.   

Abstract

Murine polyomavirus small t antigen (PyST) regulates cell cycle, cell survival, apoptosis, and differentiation and cooperates with middle T antigen (MT) to transform primary cells in vitro and in vivo. Like all polyomavirus T antigens, PyST functions largely via its interactions with host cell proteins. Here, we show that PyST binds both Yes-associated protein 1 (YAP1) and YAP2, integral parts of the Hippo signaling pathway, which is a subject of increasing interest in human cancer. The transcription factor TEAD, which is a known target of YAP, is also found in PyST complexes. PyST enhanced YAP association with protein phosphatase 2A (PP2A), leading to decreased YAP phosphorylation. PyST increased YAP levels by decreasing its degradation. This effect was mediated by a reduction in YAP association with β-transducin repeat protein (βTRCP), which is known to regulate YAP turnover in a phosphorylation-dependent manner. Genetic analysis has identified PyST mutants defective in YAP binding. These mutants demonstrated that YAP binding is important for PyST to block myoblast differentiation and to synergize with the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX) to promote cell death in 3T3-L1 preadipocytes placed under differentiation conditions. In addition to YAP binding, both of these phenotypes require PyST binding to PP2A. Importance: The Hippo/YAP pathway is a highly conserved cascade important for tissue development and homeostasis. Defects in this pathway are increasingly being associated with cancer. Polyomavirus small t antigen is a viral oncogene that cooperates with middle T antigen in transformation. On its own, small t antigen controls cell survival and differentiation. By binding YAP, small t antigen brings it together with protein phosphatase 2A. This work shows how this association of small t antigen with YAP is important for its effects on cell phenotype. It also suggests that PyST can be used to characterize cellular processes that are regulated by YAP.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122798      PMCID: PMC4178709          DOI: 10.1128/JVI.01399-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner.

Authors:  Shaida Andrabi; Ole V Gjoerup; Jennifer A Kean; Thomas M Roberts; Brian Schaffhausen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

Review 2.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

3.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.

Authors:  Masaki Mori; Robinson Triboulet; Morvarid Mohseni; Karin Schlegelmilch; Kriti Shrestha; Fernando D Camargo; Richard I Gregory
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

Review 4.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.

Authors:  Xaralabos Varelas
Journal:  Development       Date:  2014-04       Impact factor: 6.868

5.  Protein phosphatase 2A isoforms utilizing Aβ scaffolds regulate differentiation through control of Akt protein.

Authors:  Justin H Hwang; Tao Jiang; Shreya Kulkarni; Nathalie Faure; Brian S Schaffhausen
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

6.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

Authors:  Sabrina Strano; Olimpia Monti; Natalia Pediconi; Alessia Baccarini; Giulia Fontemaggi; Eleonora Lapi; Fiamma Mantovani; Alexander Damalas; Gennaro Citro; Ada Sacchi; Giannino Del Sal; Massimo Levrero; Giovanni Blandino
Journal:  Mol Cell       Date:  2005-05-13       Impact factor: 17.970

7.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

8.  Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation.

Authors:  Yanhui Xu; Yu Chen; Ping Zhang; Philip D Jeffrey; Yigong Shi
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

9.  Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ.

Authors:  Cai Bin Cui; Lyndon F Cooper; Xiangli Yang; Gerard Karsenty; Ikramuddin Aukhil
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment.

Authors:  Alexandra M Fajardo; Gary A Piazza; Heather N Tinsley
Journal:  Cancers (Basel)       Date:  2014-02-26       Impact factor: 6.639

View more
  16 in total

1.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 2.  Large T and small T antigens of Merkel cell polyomavirus.

Authors:  Justin A Wendzicki; Patrick S Moore; Yuan Chang
Journal:  Curr Opin Virol       Date:  2015-02-11       Impact factor: 7.090

3.  STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.

Authors:  Jong Wook Kim; Christian Berrios; Miju Kim; Amy E Schade; Guillaume Adelmant; Huwate Yeerna; Emily Damato; Amanda Balboni Iniguez; Laurence Florens; Michael P Washburn; Kim Stegmaier; Nathanael S Gray; Pablo Tamayo; Ole Gjoerup; Jarrod A Marto; James DeCaprio; William C Hahn
Journal:  Elife       Date:  2020-01-08       Impact factor: 8.140

4.  The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway.

Authors:  Melissa Z Mui; Yiwang Zhou; Paola Blanchette; Naila Chughtai; Jennifer F Knight; Tina Gruosso; Andreas I Papadakis; Sidong Huang; Morag Park; Anne-Claude Gingras; Philip E Branton
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

5.  Tandem Affinity Purification and Mass Spectrometry (TAP-MS) for the Analysis of Protein Complexes.

Authors:  Guillaume Adelmant; Brijesh K Garg; Maria Tavares; Joseph D Card; Jarrod A Marto
Journal:  Curr Protoc Protein Sci       Date:  2019-02-01

6.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 7.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

Review 8.  The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.

Authors:  Peter P Ruvolo
Journal:  BBA Clin       Date:  2016-08-03

9.  The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.

Authors:  Chunbo He; Dagan Mao; Guohua Hua; Xiangmin Lv; Xingcheng Chen; Peter C Angeletti; Jixin Dong; Steven W Remmenga; Kerry J Rodabaugh; Jin Zhou; Paul F Lambert; Peixin Yang; John S Davis; Cheng Wang
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

10.  Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.

Authors:  Furong Xie; Xin Bao; Jingshuang Yu; Wantao Chen; Lizhen Wang; Zhiyuan Zhang; Qin Xu
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.